Enzymes involved in the bioconversion of ester-based prodrugs

Journal of Pharmaceutical Sciences
Bianca M Liederer, Ronald T Borchardt

Abstract

Enzymes are essential for the activation of many prodrugs. In this review, the most important enzymes (e.g., paraoxonase, carboxylesterase, acetylcholinesterase, cholinesterase) involved in the bioconversion of ester-based prodrugs will be discussed in terms of their biology and biochemistry. Most of these enzymes fall into the category of hydrolytic enzymes. However, nonhydrolytic enzymes, including cytochrome P450s, can also catalyze the bioconversion of ester prodrugs and thus will be discussed here. Other factors influencing the ability of these enzymes to catalyze the bioconversion of ester-based prodrugs, particularly species and interindividual differences and stereochemical and structural features of the prodrugs, will be discussed.

References

Dec 1, 1975·Journal of Neurochemistry·L A Wade, R Katzman
Aug 1, 1991·Biochemical Society Transactions·A J Ketterman
Nov 1, 1989·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·P BerninsoneJ Azcurra
Jan 1, 1988·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·J P SineB Colas
Jan 1, 1987·Drug Metabolism Reviews·F J Leinweber
May 1, 1985·Drugs·V J StellaV H Naringrekar
Sep 1, 1985·Clinical Pharmacokinetics·F M Williams
Jan 8, 1968·Biochimica Et Biophysica Acta·R S Holmes, C J Masters
Jan 1, 1982·Annual Review of Neuroscience·J Massoulié, S Bon
Nov 15, 1983·Biochemical Pharmacology·C H Walker, M I Mackness
Aug 1, 1995·Journal of Neuroscience Research·G Sánchez-ChávezR Salceda
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·R C SorensonB N La Du
Feb 1, 1995·Experimental Eye Research·J B HutchinsV E Jefferson
Jan 1, 1994·Annual Review of Pharmacology and Toxicology·P Taylor, Z Radić
Oct 5, 1993·Biochemical Pharmacology·N W McCrackenF M Williams
Jan 25, 1994·Biochemistry·G J KelsoJ A Harmony
Jul 1, 1993·Progress in Neurobiology·J MassouliéF M Vallette
Jun 1, 1993·Chemico-biological Interactions·F GilE Villanueva
Jan 1, 1996·The Journal of Antimicrobial Chemotherapy·A J Hutt, J O'Grady
Aug 1, 1996·Archives of Biochemistry and Biophysics·R M LaethemG K Smith
Jan 1, 1996·Drugs·A J Hutt, S C Tan
Nov 5, 1997·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M R IslamI D Bowen
Jan 1, 1998·Journal of Biochemical and Molecular Toxicology·M C GonzalvoA Pla
Mar 7, 1998·European Journal of Biochemistry·A YoshidaC Chang

❮ Previous
Next ❯

Citations

Mar 27, 2012·Applied Microbiology and Biotechnology·Joana LamegoAna S Coroadinha
Apr 23, 2010·Journal of Industrial Microbiology & Biotechnology·Jeong-Keun KimYoung-Hee Lim
Nov 26, 2008·Bulletin of Experimental Biology and Medicine·G I NezhinskayaN S Sapronov
Sep 28, 2007·Pharmaceutical Research·Huaizhong PanJindrich Kopecek
Jun 17, 2010·Pharmaceutical Research·Giridhar ThiagarajanHamidreza Ghandehari
Jan 26, 2008·Nature Reviews. Drug Discovery·Jarkko RautioJouko Savolainen
May 8, 2010·Chemical Communications : Chem Comm·Nan DaiEric T Kool
Feb 24, 2010·The Journal of Biological Chemistry·Tomoko IshizukaOsamu Okazaki
Feb 8, 2008·The Journal of Biological Chemistry·Longsheng LaiGordon L Amidon
Mar 9, 2013·The Journal of Antimicrobial Chemotherapy·Sang Hoon SongJunghan Song
Jun 28, 2011·Arhiv za higijenu rada i toksikologiju·Anita BosakZrinka Kovarik
Oct 27, 2012·Advanced Drug Delivery Reviews·Balvinder S VigJarkko Rautio
Oct 16, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Arik DahanShimon Ben-Shabat
Aug 19, 2007·Journal of Pharmaceutical Sciences·Fujun LiTom Alfredson
Sep 29, 2011·Drug Metabolism Reviews·Antje HavemeyerBernd Clement
Jul 7, 2011·Expert Opinion on Drug Discovery·Thomas J Smith
Jun 19, 2012·Expert Opinion on Drug Delivery·Arik DahanRafik Karaman
Mar 13, 2014·Journal of Pharmaceutical Sciences·Katsuhiko SuedaMichael Jay
Sep 8, 2015·Journal of Pharmaceutical Sciences·Jing FuMichael Jay
Jul 27, 2012·Journal of Pharmaceutical Sciences·Fatma Goksin BaharTeruko Imai
May 31, 2012·Journal of Pharmaceutical Sciences·Katsuhiko SuedaMichael Jay
Feb 16, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·H M KimK Lee
Dec 19, 2014·Proceedings of the National Academy of Sciences of the United States of America·T Justin RettenmaierJames A Wells
Aug 14, 2012·Pharmacology & Therapeutics·Christina S WonMary F Paine
Jul 17, 2012·Environmental Toxicology and Pharmacology·Petek Piner, Nevin Üner
Sep 1, 2011·Antiviral Research·Adrian S Ray, Karl Y Hostetler
Feb 22, 2011·Advanced Drug Delivery Reviews·Rubi MahatoKun Cheng
Aug 27, 2014·Molecular Pharmaceutics·Carlos N SanrameOrn Almarsson
Oct 24, 2009·Journal of Pharmaceutical and Biomedical Analysis·Matthias KoitkaHans-Hubert Borchert
Nov 21, 2015·Chemico-biological Interactions·Hong PengOksana Lockridge
Dec 3, 2015·ACS Chemical Biology·Kristen A AndersenRonald T Raines
Jan 10, 2009·Biomaterials·M L López DonaireJ San Román

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.